Chartoreg Trio 5/12,5/80 mg 28 tablets

Chartoreg Trio 5/12,5/80 mg 28 tablets

Composition: 

Amlodipine 5 mg.
Hydrochlorothiazide 12.5 mg.
Telmisartan 80 mg.
Excipients, film-coated tablet shell.

Product Description: 

Chartoreg Trio is a fixed-dose combination antihypertensive medication.
It combines a calcium channel blocker (amlodipine), a thiazide diuretic (hydrochlorothiazide), and an angiotensin II receptor blocker (telmisartan).
This triple therapy is designed to effectively lower blood pressure and reduce cardiovascular risk.

Indications for Use: 

Indicated for the treatment of essential hypertension in patients requiring combination therapy to achieve adequate blood pressure control.

Method of Administration and Dosage: 

Administer orally once daily, with or without food.
Dosage should be individualized based on patient response and clinical judgment.
Tablets should be swallowed whole with water.

Contraindications: 

Hypersensitivity to any active ingredient or excipients.
Contraindicated in pregnancy, severe renal impairment, severe hepatic impairment, and in patients with refractory hypokalemia or hypercalcemia.

Precautions: 

Monitor blood pressure, renal function, and electrolytes regularly.
Use with caution in patients with impaired kidney or liver function, heart failure, or electrolyte imbalance.

Adverse Reactions (Side Effects): 

Possible dizziness, headache, peripheral edema, fatigue, gastrointestinal disturbances, electrolyte imbalance, or rare allergic reactions.

Pregnancy and Lactation: 

Contraindicated during pregnancy.
Not recommended during lactation unless clearly necessary and prescribed by a physician.

Storage Conditions: 

Store below 30°C in the original packaging, protected from moisture and direct sunlight.
Keep out of the reach of children.

Packaging: 

Carton containing blister packs of 28 film-coated tablets.